Efficacy of three innovative bacterin vaccines against experimental infection with Mycoplasma hyopneumoniae

New vaccine formulations that include novel strains of Mycoplasma hyopneumoniae and innovative adjuvants designed to induce cellular immunity could improve vaccine efficacy against this pathogen. The aim of this experimental study was to assess the efficacy of three experimental bacterin formulation...

Descripción completa

Detalles Bibliográficos
Autores principales: Matthijs, Anneleen Marguerite Filip, Auray, Gaël, Boyen, Filip, Schoos, Alexandra, Michiels, Annelies, García-Nicolás, Obdulio, Barut, Güliz Tuba, Barnier-Quer, Christophe, Jakob, Virginie, Collin, Nicolas, Devriendt, Bert, Summerfield, Artur, Haesebrouck, Freddy, Maes, Dominiek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6842239/
https://www.ncbi.nlm.nih.gov/pubmed/31703726
http://dx.doi.org/10.1186/s13567-019-0709-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6842239/
https://www.ncbi.nlm.nih.gov/pubmed/31703726
http://dx.doi.org/10.1186/s13567-019-0709-0

Ejemplares similares